PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för all-trans-3,4-didehydroretinoic acid. Visa hela publikationsregistret

Vad säger studierna?

Här kan du läsa sammanställningar från utvalda delar av forskningsartiklar. En enskild studie visar en del av bilden och ger inte i sig råd om att använda ett tillskott.

FORSKNINGSUTDRAG

The effect of two endogenous retinoids on the mRNA expression profile in human primary keratinocytes, focusing on genes causing autosomal recessive congenital ichthyosis. ↗

Törmä H, Bergström A, Ghiasifarahani G, Berne B.

Vad undersöktes?

Hur undersöktes det?
The aim of this study was to examine whether the two endogenous retinoids atRA and ddRA affect the mRNA expression profile differently in cultured human primary keratinocytes
Vilka undersöktes?
Primary keratinocytes from a lightly pigmented female donor (42 years) were used at passage 3
Vilken ämnesform?
ddRA
Vilken mängd användes?
1 µM of atRA, ddRA or vehicle (ethanol)
Hur länge pågick studien?
for 4 and 24 h

Studieuppgifterna återges som originalcitat. Uppgifter som saknas här kan finnas i originalutdraget.

Vad kom studien fram till?

Författarna rapporterar att ddRA vid en koncentration av 1 µM påverkade genuttrycket i differentierade primära mänskliga keratinocyter på liknande sätt som atRA, och att ingen enskild gen reglerades differentierat mellan de två retinoiderna.

Vad behöver resultatet vägas mot?

Underlaget omfattar endast utvalda artikelstycken; någon samlad bedömning kan inte göras.

Läs de originalstycken som sammanställningen bygger på
Introduction

The aim of this study was to examine whether the two endogenous retinoids atRA and ddRA affect the mRNA expression profile differently in cultured human primary keratinocytes using oligonucleotide arrays. All genes causing ARCI were analyzed in detail. The expression profiles after retinoid treatment were examined both in proliferating and differentiated keratinocytes, as representatives for basal and suprabasal epidermal keratinocytes, respectively.

Materials

atRA and ddRA were obtained from Sigma-Aldrich (Stockholm, Sweden) and Roche AG (Basle, Switzerland), respectively. The compounds were dissolved in ethanol and the concentration and purity were determined by UV absorbance and HPLC analysis, respectively. Stock solutions of 1 mM were prepared. The purity of atRA and ddRA was 99.1 and 88.3 %, respectively. The two major impurities in ddRA were 13cRA (1.5 %) and atRA (10.2 %). All handling of retinoids was performed under yellow reduced light.

Cell culture and retinoid treatment

Primary keratinocytes from a lightly pigmented female donor (42 years) were used at passage 3 (Life Technologies, Stockholm, Sweden). The cells were maintained in EpiLife serum-free keratinocyte medium containing growth supplement (HKGS or HKGS kit) and gentamicin/amphotericin (all from Life Technologies). Proliferating cells in 6-well plates at 30–40 % confluency were switched to EpiLife medium without EGF for 5 h prior to starting treatment with retinoids. Keratinocytes at 80 % confluency were switched to EpiLife− supplemented with 1.5 mM CaCl2 for 4 days with the purpose to induce cellular differentiation. Cells were subsequently exposed to retinoids as above in EpiLife medium without rhEGF. Both proliferating and differentiated cells were exposed to 1 µM of atRA, ddRA or vehicle (ethanol) for 4 and 24 h. All treatments were performed in triplicates. The cells were washed with PBS twice and frozen at −70 °C until further processing.

atRA and ddRA regulate gene expression most profoundly in differentiating keratinocytes

We compared the transcriptional profiles in atRA- and ddRA-treated keratinocytes with vehicle-treated keratinocytes. In cells exposed to one of the two retinoids, the affected RNA transcripts were few in numbers in proliferating keratinocytes as compared to differentiated cells (see Table ). The genes altered in response to atRA exposure is shown as a heat map (Online Resource 4). However, the number of altered transcripts was in the same range after treatments with both retinoids, and most of the transcripts were significantly altered by both retinoids. The top ten-induced and -suppressed annotated transcripts after atRA exposure are shown in (Online Resource 5). The expression of some genes in atRA- vs. vehicle-treated differentiating cells was verified by qPCR (Fig. b–i).

Gene expression was not regulated differently by atRA and ddRA

Although the major number of retinoid-regulated transcripts was induced or suppressed equally efficiently by atRA and ddRA, there were also transcripts that were significantly altered by only one of the retinoids when comparing to vehicle-treated controls. However, when comparing the expression profiles generated by the two retinoids with each other, no genes were significantly altered (data not shown).

Artikelns licens · ActiQs sammanfattningar och texturval är bearbetningar av källan.

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

29 träffar
Bibliografisk träff 2016-04-17

Human cytochrome P450 27C1 catalyzes 3,4-desaturation of retinoids.

Kramlinger VM, Nagy LD, Fujiwara R, Johnson KM, Phan TT, Xiao Y, Enright JM, Toomey MB, Corbo JC, Guengerich FP.

FEBS Lett · letter; research support, non-u.s. gov't; research-article; research support, u.s. gov't, non-p.h.s.; research support, n.i.h., extramural · DOI 10.1002/1873-3468.12167
Bibliografisk träff 1995-12-01

Endogenous retinoids in the early avian embryo.

Dong D, Zile MH.

Biochem Biophys Res Commun · research support, non-u.s. gov't; research support, u.s. gov't, non-p.h.s.; journal article · DOI 10.1006/bbrc.1995.2872